HomeCompareNSTGQ vs QYLD

NSTGQ vs QYLD: Dividend Comparison 2026

NSTGQ yields 2904.87% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NSTGQ wins by $334489948038.32M in total portfolio value
10 years
NSTGQ
NSTGQ
● Live price
2904.87%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$334489948038.34M
Annual income
$313,275,206,242,203,900.00
Full NSTGQ calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — NSTGQ vs QYLD

📍 NSTGQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNSTGQQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NSTGQ + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NSTGQ pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NSTGQ
Annual income on $10K today (after 15% tax)
$246,913.58/yr
After 10yr DRIP, annual income (after tax)
$266,283,925,305,873,300.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, NSTGQ beats the other by $266,283,925,305,868,500.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NSTGQ + QYLD for your $10,000?

NSTGQ: 50%QYLD: 50%
100% QYLD50/50100% NSTGQ
Portfolio after 10yr
$167244974019.18M
Annual income
$156,637,603,121,104,770.00/yr
Blended yield
93.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NSTGQ right now

NSTGQ
Analyst Ratings
4
Buy
5
Hold
Consensus: Hold
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NSTGQ buys
0
QYLD buys
0
No recent congressional trades found for NSTGQ or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNSTGQQYLD
Forward yield2904.87%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$334489948038.34M$25.4K
Annual income after 10y$313,275,206,242,203,900.00$5,659.31
Total dividends collected$333020626625.58M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: NSTGQ vs QYLD ($10,000, DRIP)

YearNSTGQ PortfolioNSTGQ Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$301,187$290,486.56$10,352$1,192.36+$290.8KNSTGQ
2$8,498,966$8,176,696.33$10,830$1,347.57+$8.49MNSTGQ
3$224,731,541$215,637,647.39$11,460$1,539.07+$224.72MNSTGQ
4$5,569,377,193$5,328,914,444.65$12,275$1,777.84+$5569.36MNSTGQ
5$129,382,652,478$123,423,418,881.28$13,323$2,078.95+$129382.64MNSTGQ
6$2,818,121,154,403$2,679,681,716,251.61$14,667$2,463.34+$2818121.14MNSTGQ
7$57,563,918,814,863$54,548,529,179,651.69$16,396$2,960.57+$57563918.80MNSTGQ
8$1,102,927,179,154,320$1,041,333,786,022,416.00$18,631$3,612.97+$1102927179.14MNSTGQ
9$19,826,861,491,718,330$18,646,729,410,023,210.00$21,548$4,482.15+$19826861491.70MNSTGQ
10$334,489,948,038,342,460$313,275,206,242,203,900.00$25,398$5,659.31+$334489948038.32MNSTGQ

NSTGQ vs QYLD: Complete Analysis 2026

NSTGQStock

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full NSTGQ Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this NSTGQ vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NSTGQ vs SCHDNSTGQ vs JEPINSTGQ vs ONSTGQ vs KONSTGQ vs MAINNSTGQ vs XYLDNSTGQ vs JEPQNSTGQ vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.